mRNA |
PD-0325901 |
gCSI |
pan-cancer |
AAC |
0.15 |
0.01 |
mRNA |
tanespimycin:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.097 |
0.01 |
mRNA |
BRD-K75293299 |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
0.01 |
mRNA |
1S,3R-RSL-3 |
CTRPv2 |
pan-cancer |
AAC |
0.081 |
0.02 |
mRNA |
KU-60019 |
CTRPv2 |
pan-cancer |
AAC |
0.084 |
0.02 |
mRNA |
Dasatinib |
CTRPv2 |
pan-cancer |
AAC |
0.087 |
0.02 |
mRNA |
erlotinib:PLX-4032 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.089 |
0.02 |
mRNA |
procarbazine |
CTRPv2 |
pan-cancer |
AAC |
0.093 |
0.02 |
mRNA |
BRD-K35604418 |
CTRPv2 |
pan-cancer |
AAC |
-0.087 |
0.02 |
mRNA |
Platin |
CTRPv2 |
pan-cancer |
AAC |
0.087 |
0.02 |